-
Zhejiang Dian Diagnostics Partners with SNN/CRHA for Optic Nerve Disease Research
•
China-based Zhejiang Dian Diagnostics Co., Ltd (SHE: 300244), a leading diagnostic solutions provider, has formed a strategic partnership with the Society for Neuroscience and Neurology, Chinese Research Hospital Association (SNN/CRHA). This collaboration is aimed at conducting comprehensive research into the genetic underpinnings of optic nerve-related diseases, marking a significant step…
-
Tigermed Announces Acquisition of Majority Stake in Shanghai Guanhe Pharmaceutical for CNY 140 Million
•
Tigermed (SHE: 300347, HKG: 3347) has announced its intention to acquire a 40.5650% stake in Shanghai Guanhe Pharmaceutical Co., Ltd (hereinafter referred to as “Guanhe Pharmaceutical”) from DiAn Diagnostics (SHE: 300244) and Suzhou Yingkai Xinyun Enterprise Management Consulting Co., Ltd (hereinafter referred to as “Suzhou Yingkai”, a subsidiary of DiAn…
-
Zhejiang Dian Diagnostics Partners with Shanghai Mycology Lab to Advance Fungal Infection Diagnostics
•
SHANGHAI—Zhejiang Dian Diagnostics Co., Ltd (SHE: 300244), a leading player in the diagnostics industry, has entered into a strategic partnership with the Shanghai Key Laboratory of Medical Mycology and Molecular Biology. The collaboration aims to delve into multi-center scientific research, product development, and the integration of artificial intelligence (AI) technology…
-
Eisai Forges Partnerships with Chinese Firms to Strengthen Alzheimer’s Disease Market Presence
•
Eisai Co., Ltd, (TYO: 4523) a Japanese pharmaceutical company, has announced separate strategic partnerships with several Chinese healthcare firms, including iKang Healthcare Group, Zhejiang Dian Diagnostics Co., Ltd (SHE: 300244), V-Medical, Kindstar Global (HKG: 9960), and Ribose. These collaborations are aimed at tapping into the Alzheimer’s disease (AD) market in…
-
Zhejiang Dian Diagnostics Partners with Quest Diagnostics to Advance Alzheimer’s Disease Blood Tests
•
Zhejiang Dian Diagnostics Co., Ltd (SHE: 300244), a leading diagnostics company based in China, has entered into a strategic partnership with Quest Diagnostics, a top global provider of diagnostic information services. The collaboration aims to develop and offer blood-based clinical research services specifically tailored for Alzheimer’s disease (AD). Through this…
-
Zhejiang Dian Diagnostics Partners with Henan Institute to Open Neuroimmunity Research Center
•
Zhejiang Dian Diagnostics Co., Ltd (SHE: 300244), a medical diagnostics company based in China, has entered into a collaboration with the Henan Institute of Medical and Pharmaceutical Sciences to establish the Engineering Technology Research Center for Accurate Diagnosis and Treatment of Neuroimmunity. The new research institute has been officially inaugurated…
-
Zhejiang Dian Diagnostics Partners with Hangzhou Medical College to Establish Education Base
•
Zhejiang Dian Diagnostics Co., Ltd (SHE: 300244), a prominent player in the medical diagnostics space, has entered into a strategic partnership with Hangzhou Medical College to establish a graduate education base focused on biology and medicine. This collaboration aims to create a conducive environment for the next generation of medical…
-
Zhejiang Dian Diagnostics Partners with Haihe Laboratory to Advance Hematology Diagnostics
•
Zhejiang Dian Diagnostics Co., Ltd (SHE: 300244), a company based in China, has entered into a strategic partnership with the Haihe Laboratory of Cell Ecosystem under the China Academy of Medical Sciences. The collaboration aims to drive research translation, standardize disease diagnosis and treatment, advance digital healthcare, and enhance discipline…
-
Zhejiang Dian Diagnostics Partners with Gulf Medical University for Middle East Expansion
•
Zhejiang Dian Diagnostics Co., Ltd (SHE: 300244), a Chinese diagnostics company, has entered into a cooperation intention agreement with the United Arab Emirates’ Gulf Medical University. The collaboration aims to encompass talent exchange, channel construction, scientific research, and commercial translational research, among other areas. Financial details of the agreement have…
